Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018

Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018

Saved in:

Bibliographic Details
Main Authors:	Alexandra Albertsson‐Lindblad, Sara Ekberg, Ingrid Glimelius, Fredrik Ellin, Kristina Sonnevi, Catharina Lewerin, Lena Brandefors, Karin E. Smedby, Mats Jerkeman
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	HemaSphere
Online Access:	https://doi.org/10.1002/hem3.70080
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to non-dysplastic metaplasia in Barrett’s esophagus: a retrospective cohort study in Sweden
by: Peter Elbe, et al.
Published: (2024-11-01)

Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study
by: Trine Trab, et al.
Published: (2025-08-01)

An Anaplastic Pleomorphic Variant of Mantle Cell Lymphoma
by: Radu Chiriac, et al.
Published: (2025-06-01)

Coexisting Mantle Cell Lymphoma and Prostate Adenocarcinoma
by: Ashish B. Rajput, et al.
Published: (2014-01-01)

Mantle cell lymphoma relapsing at the lymphedematous arm.
by: Giuseppina Massini, et al.
Published: (2013-02-01)

COEXISTENCE OF BREAST CANCER AND MANTLE CELL LYMPHOMA
by: Bengü Sezer, et al.
Published: (2024-12-01)

Mantle Cell Lymphoma of the Gastrointestinal Tract (Lymphomatous Polyposis)
by: Hugh James Freeman
Published: (1996-01-01)

Ferroptosis-related prognostic model of mantle cell lymphoma
by: Gao Qianwen, et al.
Published: (2024-11-01)

Mantle Cell Lymphoma Payudara, Suatu Kasus Jarang
by: Valencia Valencia, et al.
Published: (2021-02-01)

Acquired von Willebrand Disease Associated with Mantle Cell Lymphoma
by: Dominique Maas, et al.
Published: (2018-01-01)

Isolated central nervous system relapse in mantle cell lymphoma
by: Radu Chiriac, et al.
Published: (2025-06-01)

Blastoid Mantle Cell Lymphoma Presenting as an Isolated Cecal Mass
by: Lefika Bathobakae MD, MPH, et al.
Published: (2025-03-01)

Intestinal mantle cell lymphoma recurring at laparotomy scar region
by: Ray Amitabh, et al.
Published: (2009-12-01)

Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma
by: Prajwol Pathak, et al.
Published: (2017-01-01)

Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance
by: Xiaoqing Sun, et al.
Published: (2025-07-01)

Type B Lactic Acidosis in a Patient with Mantle Cell Lymphoma
by: Ikemsinachi C. Nzenwa, et al.
Published: (2023-01-01)

Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
by: Petković Ivan, et al.
Published: (2016-01-01)

A Single Mass Forming Colonic Primary Mantle Cell Lymphoma
by: Fady Daniel, et al.
Published: (2016-01-01)

Pathologic Rupture of the Spleen in Mantle-Cell-Type Non-Hodgkin’s Lymphoma
by: Christopher B. Tan, et al.
Published: (2012-01-01)

Mantle Cell Lymphoma of Intestine Presenting as Multiple Lymphomatous Polyposis with Intussusception
by: Meena N. Jadhav, et al.
Published: (2015-01-01)

A Rare Presentation of In Situ Mantle Cell Lymphoma and Follicular Lymphoma: A Case Report and Review of the Literature
by: Josephine Taverna, et al.
Published: (2014-01-01)

Targeting netrin‐1/DCC interaction in diffuse large B‐cell and mantle cell lymphomas
by: Laura Broutier, et al.
Published: (2016-02-01)

Mantle Zone Cell Lymphomas. New Opportunities for Diagnosis and Treatment (Epidemiological Research)
by: E. I. Kankumasheva, et al.
Published: (2020-01-01)

A Hyperacute Presentation of Small Cell, Non-Nodal Mantle Cell Lymphoma
by: Jodi Chiu, et al.
Published: (2025-01-01)

First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness
by: KD Kaplanov, et al.
Published: (2018-04-01)

Estimation of the expected change in domestic human salmonella cases in Sweden in 2010, given a hypothetical relaxation of the current salmonella control programme.
by: Helene Wahlström, et al.
Published: (2014-01-01)

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
by: Clémentine Sarkozy, et al.
Published: (2025-04-01)

The Prevalence of Polypharmacy and the Contribution of Age, Period, and Cohort Effects in Sweden From 2006 to 2020
by: Theodore T. Miao, et al.
Published: (2025-05-01)

CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma
by: Serene Xavier, et al.
Published: (2025-05-01)

Case Report: Membranous nephropathy associated with mantle cell lymphoma: a rare case
by: Mian Ren, et al.
Published: (2025-08-01)

A Case Study of a 73 -Year-Old Male with Mantle Cell Lymphoma
by: Shambhavi ., et al.
Published: (2023-01-01)

Central nervous system involvement of mantle cell lymphoma: Case report and review of the literature
by: Besim Fazıl Ağargün, et al.
Published: (2024-12-01)

MANTLE CELL LYMPHOMA PATIENT WITH SKIN GVHD AFTER AUOTOLOGOUS STEM CELL TRANSPLANT
by: Mehmet Sezgin Pepeler, et al.
Published: (2024-12-01)

Candy Cane Hypopyon Secondary to Intraocular Mantle Cell Lymphoma: A Case Report
by: Fatima Babiker, et al.
Published: (2024-12-01)

Adult Acute Megakaryoblastic Leukemia in a Mantle Cell Lymphoma Post Treatment and Auto‐Transplant
by: Chin‐Mu Hsu, et al.
Published: (2025-06-01)

Role of TRIM24 in the regulation of proteasome-autophagy crosstalk in bortezomib-resistant mantle cell lymphoma
by: Corentin Bouvier, et al.
Published: (2025-03-01)

POD24-Based prognostic signature enables personalized risk stratification in mantle cell lymphoma
by: Yizi He, et al.
Published: (2025-03-01)

Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion
by: Robert K. McCall, et al.
Published: (2020-01-01)

Multilocus Variable-Number Tandem-Repeat Analysis as an Investigation Tool in <i>Cryptosporidium parvum</i> Outbreaks in Finland and Sweden in 2022
by: Kristiina Suominen, et al.
Published: (2025-04-01)

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
by: Preetesh Jain, et al.
Published: (2023-10-01)